WB
NVO

West Bancorporation’s Novo Nordisk NVO Stock Holding History

West Bancorporation’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$12K Hold
340
– – 0.01% 214
2020
Q2 		$11K Hold
340
– – 0.01% 217
2020
Q1 		$10K Hold
340
– – 0.01% 199
2019
Q4 		$10K Buy
+340
New +$9.41K 0.01% 221

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

West Bancorporation's NVO Position: Q3 2020 in Review

West Bancorporation held its Novo Nordisk (NVO) position steady in Q3 2020 at 340 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #214.

West Bancorporation first reported a position in NVO in Q4 2019 and has held it in 4 quarters since. 659 funds tracked by Wall St. Rank hold NVO as of Q3 2020.

  • West Bancorporation held 340 shares of Novo Nordisk worth $12K as of Q3 2020.
  • West Bancorporation left its Novo Nordisk share count unchanged in Q3 2020.
  • Novo Nordisk made up 0.01% of West Bancorporation's portfolio in Q3 2020, its #214 holding.
  • West Bancorporation first reported a position in Novo Nordisk in Q4 2019 and has held it in 4 quarters since.
  • 659 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2020.

Based on West Bancorporation's 13F filing for Q3 2020, filed 30 Oct 2020.